Mainz Biomed N.V.
MYNZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.69M
Close$
$-3.88
208.1% downside
Current Fair Value
208.1% downsideOvervalued by 208.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.69 Million |
|---|---|
| Enterprise Value | $1.32 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.7 |
| Beta | 0.32 |
| Outstanding Shares | 17,851,499 |
Return
| Return on Equity | -185.89% |
|---|---|
| Return on Assets | -161.99% |
| Return on Invested Capital | -180.70% |
Valuation & Multiples
| P/E Ratio | -3.02 |
|---|---|
| PEG | -9.44 |
| Price to Sales | - |
| Price to Book Ratio | 3.59 |
| Enterprise Value to Revenue | 1.44 |
| Enterprise Value to EBIT | -0.04 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 14, 2026
EPS Estimate
$-1.01
Average shareholder expectationRevenue Estimate
$670,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.04%▼ 13.83% |
|---|---|
| Total Invested | $143,547▼ 88.67% |
| Investors Holding | 16▼ 2.00% |
ESG Score
No data